Sepsis Diagnostics Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The rising prevalence of infectious diseases and hospital-associated infections (HAI) that can trigger sepsis, especially in the elderly population, newborn babies, and people suffering from chronic ailments. For instance, in any developed country, 7 out of every 100 hospitalized patients probably develop hospital-acquired infections, while this number is expected to rise to 10 in developing countries owing to its not so well-maintained healthcare infrastructure, as per the WHO. Thus, with the rapid increase in HAIs across the globe, there is a surging demand for effective sepsis diagnostic solutions.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18431

The recent COVID-19 pandemic has disrupted the healthcare industry with the emergence of SARS-COV-2 and the huge number of infected patients has significantly impacted the sepsis diagnostics market. this is because of the increase in the number of patients that are at a high risk of developing sepsis. Also, according to a recent study among the non-survivors of COVID-19, almost 50% had a secondary infection, 100% of these had sepsis, and about 70% had septic shock. Owing to this, there has been an increasing demand for sepsis diagnostics solutions globally.

According to UnivDatos Market Insights (UMI)’ research report “Global Sepsis Diagnostics Market Analysis, 2020”, the sepsis diagnostics market is projected to grow at a CAGR of around 9% during 2021-27F. Promulgating strategic alliances is one of the prominent factors leading to the growth of the sepsis diagnostics market globally. For example, in September 2020, Roche Diagnostics and Inotrem collaborated to develop the sTREM-1 test, a diagnostic solution for sepsis.

Request Sample Copy of this Report @ https://univdatos.com/get-a-free-sample-form-php/?product_id=18431

Based on the test type, the market is fragmented into laboratory tests and point-of-care (POC) tests. The laboratory tests segment accounted for a considerable share in 2020 and is anticipated to register a lucrative CAGR during the forecast period. The growth of this segment is attributed to the greater of laboratory testing in comparison to POC testing while diagnosing sepsis. Also, the presence of technologically advanced products in these laboratories has made the reliance of the public and physicians on these labs which in turn is also boosting the segment growth. However, POC testing is expected to grow significantly during the forecast period owing to the new launches of rapid diagnosis assay kits in the market.

Hospitals & Specialty Clinics Segment to Witness Robust growth

Based on end-users, the market is segmented into hospitals & specialty clinics, pathology & reference laboratories, and others. The hospitals & specialty clinics segment had the highest revenue and CAGR growth in the analyzed period as hospitals are the surge in the number of patients hospitalization and presence of in-house diagnostic laboratories in the hospital setting that performs a large number of blood culture tests.

For more informative information, please visit us @ https://univdatos.com/report/sepsis-diagnostics-market/

North America to Grab Lion’s Share, and Asia-Pacific witnessed Explicit Growth

Based on the region, North America dominated the global sepsis diagnostics market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established healthcare infrastructure and growing adoption of advanced diagnostics systems in the region. Asia-Pacific is expected to skyrocket with a CAGR of X% in the forecast period owing, as stated in UnivDatos Market Insights (UMI)’ research report “Global Sepsis Diagnostics Market Analysis, 2020”. 

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Sepsis Diagnostics Market include Danaher Corporation, BioMérieux, Becton, Dickinson and Company, Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Luminex Corporation, T2 Biosystems, EKF Diagnostics, Immunexpress, among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

For more informative information, please visit us @ https://univdatos.com/report/sepsis-diagnostics-market/

“Global Sepsis Diagnostics Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for sepsis diagnostics providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

Market Segmentation:

1.      By Technology (Microbiology, Immunoassays, Molecular Diagnostics, and Flow Cytometry)

2.      By Product (Blood Culture Media, Assay & Reagents, Instruments, and Software)

3.      By Pathogen (Bacterial, Fungal, Viral, and Others)

4.      By Test Type (Laboratory Tests and Point-Of-Care (POC) Tests)

5.      By End-Users (Hospitals & Specialty Clinics, Pathology & Reference Laboratories, and Others)

6.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

7.      By Company (Danaher Corporation, BioMérieux, Becton, Dickinson and Company, Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, Luminex Corporation, T2 Biosystems, EKF Diagnostics, Immunexpress, etc.)

Key questions answered in the study:

1.      What are the current and future trends of the sepsis diagnostics industry?

2.      How the industry has been evolving in terms of technology, product, pathogen, test-type, and end-users?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the sepsis diagnostics industry?

5.      What is the customer orientation, purchase behavior, and expectations from sepsis diagnostics firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 GLOBAL SEPSIS DIAGNOSTICS MARKET REVENUE

7 MARKET INSIGHTS BY TECHNOLOGY

8 MARKET INSIGHTS BY PRODUCT

9 MARKET INSIGHTS BY PATHOGEN

10 MARKET INSIGHTS BY TEST TYPE

11 MARKET INSIGHTS BY END-USERS

12 MARKET INSIGHTS BY REGION

13 SEPSIS DIAGNOSTICS MARKET DYNAMICS

14 SEPSIS DIAGNOSTICS MARKET OPPORTUNITIES

15 SEPSIS DIAGNOSTICS MARKET TRENDS & INSIGHTS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

20 COMPANY PROFILED

21 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        Ventilator Market is expected to foresee steady growth by 2027|CAGR: 8%

·        Antiviral Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4%

·        Diagnostics Advancement along with several R&D investments Drives the Genomics Market

·        Cancer Immunotherapy Market: Current Analysis and Forecast 2021-2027